Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

01.08.2022

2 Biochem Biophys Res Commun
2 BMJ
2 J Immunol
1 J Infect Dis
8 J Virol
5 JAMA
1 Lancet
3 Minerva Pediatr (Torino)
3 MMWR Morb Mortal Wkly Rep
3 PLoS Comput Biol
30 PLoS One
4 Proc Natl Acad Sci U S A
1 Virology



    Biochem Biophys Res Commun

  1. BEHERA J, Ison J, Voor MJ, Tyagi SC, et al
    Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss.
    Biochem Biophys Res Commun. 2022;620:180-187.
    >> Share

  2. MISHRA PM, Anjum F, Uversky VN, Nandi CK, et al
    SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors.
    Biochem Biophys Res Commun. 2022;620:8-14.
    >> Share


    BMJ

  3. DE FOO C, Haldane V, Jung AS, Grepin KA, et al
    Isolation facilities for covid-19: towards a person centred approach.
    BMJ. 2022;378:e069558.
    >> Share

  4. WISE J
    Covid-19: Infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds.
    BMJ. 2022;378:o1838.
    >> Share


    J Immunol

  5. SEBINA I, Rashid RB, Sikder MAA, Rahman MM, et al
    IFN-lambda Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by Limiting NADPH Oxidase-Induced PAD4-Independent NETosis.
    J Immunol. 2022;208:2806-2816.
    >> Share

  6. CHEN Y, Ye Z, Zhang Y, Xie W, et al
    A Deep Learning Model for Accurate Diagnosis of Infection Using Antibody Repertoires.
    J Immunol. 2022;208:2675-2685.
    >> Share


    J Infect Dis

  7. BRITTO C, Mohorianu I, Yeung T, Cheung E, et al
    Host respiratory transcriptome signature associated with poor outcome in children with influenza-Staphylococcus aureus pneumonia.
    J Infect Dis. 2022 Jul 28. pii: 6650994. doi: 10.1093.
    >> Share


    J Virol

  8. CHEN X, Li J, Yang L, Zhou Y, et al
    Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
    J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
    >> Share

  9. SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
    A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
    >> Share

  10. LAVIE M, Dubuisson J, Belouzard S
    SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
    >> Share

  11. BEACH SS, Hull MA, Ytreberg FM, Patel JS, et al
    Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein.
    J Virol. 2022;96:e0035322.
    >> Share

  12. SUN C, Yuan RY, Xie C, Sun JF, et al
    Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
    >> Share

  13. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    >> Share

  14. CHAN CE, Ng CG, Lim AP, Seah SL, et al
    The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
    J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
    >> Share

  15. BI W, Chen G, Dang B
    Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
    J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
    >> Share


    JAMA

  16. ZENG G
    SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
    JAMA. 2022;328:395.
    >> Share

  17. ULLOA AC, Buchan SA, Brown KA
    SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.
    JAMA. 2022;328:395-396.
    >> Share

  18. SLOMSKI A
    Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.
    JAMA. 2022;328:322.
    >> Share

  19. KUEHN BM
    Persistent Disparities in COVID-19 Antiviral Dispensing.
    JAMA. 2022;328:323.
    >> Share

  20. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
    Changes in the Relationship Between Income and Life Expectancy Before and During the COVID-19 Pandemic, California, 2015-2021.
    JAMA. 2022 Jul 7. pii: 2794146. doi: 10.1001/jama.2022.10952.
    >> Share


    Lancet

  21. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    >> Share


    Minerva Pediatr (Torino)

  22. YASMIN F, Farhan SA, Ochani RK, Mangi AR, et al
    An unusual inflammatory disease linked to SARS Coronavirus-2 in children: are we prepared enough?
    Minerva Pediatr (Torino). 2022;74:478-479.
    >> Share

  23. TRABACCA A, Craig F
    Social distancing and social interaction in children with autism spectrum disorder during the COVID-19 pandemic: a clinical oxymoron.
    Minerva Pediatr (Torino). 2022;74:481-482.
    >> Share

  24. VITTORI A, Marchetti G, Francia E, Mascilini I, et al
    Organization of a pediatric acupuncture clinic for pain and enuresis during COVID-19 pandemic in a third level Italian pediatric hospital: experience of the Bambino Gesu Children's Hospital.
    Minerva Pediatr (Torino). 2022;74:480-481.
    >> Share


    MMWR Morb Mortal Wkly Rep

  25. LINK-GELLES R, Levy ME, Gaglani M, Irving SA, et al
    Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:931-939.
    >> Share

  26. KONE A, Horter L, Thomas I, Byrkit R, et al
    Symptoms of Mental Health Conditions and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers - United States, March 14-25, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:925-930.
    >> Share

  27. HARE BORK R, Robins M, Schaffer K, Leider JP, et al
    Workplace Perceptions and Experiences Related to COVID-19 Response Efforts Among Public Health Workers - Public Health Workforce Interests and Needs Survey, United States, September 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:920-924.
    >> Share


    PLoS Comput Biol

  28. PAIK H, Kim J, Seo S
    Analysis of the docking property of host variants of hACE2 for SARS-CoV-2 in a large cohort.
    PLoS Comput Biol. 2022;18:e1009834.
    >> Share

  29. JOO R, Sanchez-Tapia A, Mortara S, Bellini Saibene Y, et al
    Ten simple rules to host an inclusive conference.
    PLoS Comput Biol. 2022;18:e1010164.
    >> Share

  30. TAO J, Wang H, Wang W, Mi N, et al
    Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs.
    PLoS Comput Biol. 2022;18:e1010343.
    >> Share


    PLoS One

  31. KARNAZE MM, Bellettiere J, Bloss CS
    Association of compassion and empathy with prosocial health behaviors and attitudes in a pandemic.
    PLoS One. 2022;17:e0271829.
    >> Share

  32. MOHR NM, Krishnadasan A, Harland KK, Ten Eyck P, et al
    Emergency department personnel patient care-related COVID-19 risk.
    PLoS One. 2022;17:e0271597.
    >> Share

  33. GUJJULA KR, Gong J, Segundo B, Ntaimo L, et al
    COVID-19 vaccination policies under uncertain transmission characteristics using stochastic programming.
    PLoS One. 2022;17:e0270524.
    >> Share

  34. HASSAN S, Ferrari B, Rossio R, la Mura V, et al
    The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy.
    PLoS One. 2022;17:e0264106.
    >> Share

  35. MINATO T, Yamaguchi T, Hoshizaki M, Nirasawa S, et al
    ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury.
    PLoS One. 2022;17:e0270920.
    >> Share

  36. CORDOBA-LANUS E, Garcia-Perez O, Rodriguez-Esparragon F, Bethencourt-Estrella CJ, et al
    Ozone treatment effectively eliminates SARS-CoV-2 from infected face masks.
    PLoS One. 2022;17:e0271826.
    >> Share

  37. NASH D, Qasmieh S, Robertson M, Rane M, et al
    Household factors and the risk of severe COVID-like illness early in the U.S. pandemic.
    PLoS One. 2022;17:e0271786.
    >> Share

  38. BRINKMANN C, Gohl P, Mack D, Pfeifer J, et al
    The importance of effect sizes when comparing cycle threshold values of SARS-CoV-2 variants.
    PLoS One. 2022;17:e0271808.
    >> Share

  39. LIU B, Zhang M, Li X, Liu L, et al
    Influence of epidemic situation on COVID-19 vaccination between urban and rural residents in China-Vietnam border area: A cross-sectional survey.
    PLoS One. 2022;17:e0270345.
    >> Share

  40. HERMAN B, Wong MC, Viwattanakulvanid P
    Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study.
    PLoS One. 2022;17:e0271385.
    >> Share

  41. ACEVEDO A, Feng W, Corlin L, Allen JD, et al
    Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020.
    PLoS One. 2022;17:e0271788.
    >> Share

  42. SWANSON T, Guikema S, Bagian J, Schemanske C, et al
    COVID-19 aerosol transmission simulation-based risk analysis for in-person learning.
    PLoS One. 2022;17:e0271750.
    >> Share

  43. DEWA CS, Che Z, Guggenbickler AM, Phan R, et al
    Building a public health workforce for a university campus during a pandemic using a practicum framework: Design and outcomes.
    PLoS One. 2022;17:e0270488.
    >> Share

  44. BAILEY DP, Wells AV, Desai T, Sullivan K, et al
    Physical activity and sitting time changes in response to the COVID-19 lockdown in England.
    PLoS One. 2022;17:e0271482.
    >> Share

  45. HANSON CK, Liu K
    Think about your friends and family: The disparate impacts of relationship-centered messages on privacy concerns, protective health behavior, and vaccination against Covid-19.
    PLoS One. 2022;17:e0270279.
    >> Share

  46. JUNGE M, Li S, Samaranayake S, Zalesak M, et al
    Safe reopening of university campuses is possible with COVID-19 vaccination.
    PLoS One. 2022;17:e0270106.
    >> Share

  47. PUHACHEUSKAYA V, Hubert Lyall I, Jarvikivi J
    COVIDisgust: Language processing through the lens of partisanship.
    PLoS One. 2022;17:e0271206.
    >> Share

  48. ZHU H, Liu S, Zheng W, Belay H, et al
    Assessing the dynamic impacts of non-pharmaceutical and pharmaceutical intervention measures on the containment results against COVID-19 in Ethiopia.
    PLoS One. 2022;17:e0271231.
    >> Share

  49. SEO SM, Son JH, Lee JH, Kim NW, et al
    Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
    PLoS One. 2022;17:e0272019.
    >> Share

  50. KINOSHITA K, Ozato N, Yamaguchi T, Mori K, et al
    Association between visceral fat and influenza infection in Japanese adults: A population-based cross-sectional study.
    PLoS One. 2022;17:e0272059.
    >> Share

  51. AREM H, Moses J, Nekhlyudov L, Killackey M, et al
    Oncology provider experiences during the COVID-19 pandemic.
    PLoS One. 2022;17:e0270651.
    >> Share

  52. SAMADBEIK M, Garavand A, Aslani N, Ebrahimzadeh F, et al
    Assessing the online search behavior for COVID-19 outbreak: Evidence from Iran.
    PLoS One. 2022;17:e0267818.
    >> Share

  53. ARJARQUAH AK, Obodai E, Anie HA, Osei MA, et al
    Occurrence of influenza and bacterial infections in cancer patients receiving radiotherapy in Ghana.
    PLoS One. 2022;17:e0271877.
    >> Share

  54. GOTO T, Tani N, Ikematsu H, Gondo K, et al
    Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
    PLoS One. 2022;17:e0272056.
    >> Share

  55. MARCHETTI S, Borin A, Conteduca FP, Ilardi G, et al
    An epidemic model for SARS-CoV-2 with self-adaptive containment measures.
    PLoS One. 2022;17:e0272009.
    >> Share

  56. BENNETTS SK, Crawford SB, Howell TJ, Burgemeister F, et al
    Parent and child mental health during COVID-19 in Australia: The role of pet attachment.
    PLoS One. 2022;17:e0271687.
    >> Share

  57. CLARK-BOUCHER D, Boss J, Salvatore M, Smith JA, et al
    Assessing the added value of linking electronic health records to improve the prediction of self-reported COVID-19 testing and diagnosis.
    PLoS One. 2022;17:e0269017.
    >> Share

  58. THIESSEN M, Soriano A, Park J, Decker K, et al
    Fit theory: A cancer experience grounded theory emerging from semi-structured interviews with cancer patients and informal caregivers in Manitoba Canada during the COVID-19 pandemic.
    PLoS One. 2022;17:e0269285.
    >> Share

  59. BLANCHFLOWER DG, Bryson A
    Covid and mental health in America.
    PLoS One. 2022;17:e0269855.
    >> Share

  60. ZAMANZADEH A, Cavoli T
    The effect of nonpharmaceutical interventions on COVID-19 infections for lower and middle-income countries: A debiased LASSO approach.
    PLoS One. 2022;17:e0271586.
    >> Share


    Proc Natl Acad Sci U S A

  61. VU MN, Lokugamage KG, Plante JA, Scharton D, et al
    QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.
    Proc Natl Acad Sci U S A. 2022;119:e2205690119.
    >> Share

  62. XU Z, Choi JH, Dai DL, Luo J, et al
    SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation.
    Proc Natl Acad Sci U S A. 2022;119:e2204539119.
    >> Share

  63. GUO K, Barrett BS, Morrison JH, Mickens KL, et al
    Interferon resistance of emerging SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2022;119:e2203760119.
    >> Share

  64. IOANNIDIS JPA, Bendavid E, Salholz-Hillel M, Boyack KW, et al
    Massive covidization of research citations and the citation elite.
    Proc Natl Acad Sci U S A. 2022;119:e2204074119.
    >> Share


    Virology

  65. HAN M, Gao S, Hu W, Zhou Q, et al
    Inhibitory effects of cedar pine needle extract on H9N2 avian influenza virus in vitro and in vivo.
    Virology. 2022;574:25-36.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016